Raymond James & Associates’s ARK Genomic Revolution ETF ARKG Stock Holding History

Raymond James & Associates’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.55M	Sell	60,535 -21,876	-27%	-$557K	﹤0.01%	2398
2024 Q2	$1.93M	Sell	82,411 -32,104	-28%	-$810K	﹤0.01%	2190
2024 Q1	$3.29M	Sell	114,515 -4,666	-4%	-$140K	﹤0.01%	1856
2023 Q4	$3.91M	Sell	119,181 -12,172	-9%	-$331K	﹤0.01%	1693
2023 Q3	$3.66M	Sell	131,353 -6,054	-4%	-$198K	﹤0.01%	1654
2023 Q2	$4.68M	Buy	137,407 +2,948	+2%	+$92.7K	﹤0.01%	1523
2023 Q1	$4.04M	Sell	134,459 -13,222	-9%	-$410K	﹤0.01%	1610
2022 Q4	$4.17M	Sell	147,681 -57,686	-28%	-$1.83M	﹤0.01%	1524
2022 Q3	$6.75M	Buy	205,367 +33,730	+20%	+$1.24M	0.01%	1174
2022 Q2	$5.41M	Sell	171,637 -2,887	-2%	-$101K	0.01%	1350
2022 Q1	$8.02M	Sell	174,524 -46,671	-21%	-$2.23M	0.01%	1199
2021 Q4	$13.5M	Sell	221,195 -42,799	-16%	-$2.96M	0.01%	941
2021 Q3	$19.7M	Sell	263,994 -32,120	-11%	-$2.69M	0.02%	715
2021 Q2	$27.4M	Buy	296,114 +22,443	+8%	+$1.91M	0.02%	557
2021 Q1	$24.3M	Sell	273,671 -38,540	-12%	-$3.82M	0.02%	576
2020 Q4	$29.1M	Buy	312,211 +4,895	+2%	+$390K	0.03%	461
2020 Q3	$19.6M	Buy	307,316 +98,749	+47%	+$5.79M	0.02%	547
2020 Q2	$10.9M	Buy	208,567 +109,082	+110%	+$4.68M	0.01%	783
2020 Q1	$3.11M	Sell	99,485 -4,683	-4%	-$156K	﹤0.01%	1316
2019 Q4	$3.49M	Sell	104,168 -108,143	-51%	-$3.44M	﹤0.01%	1492
2019 Q3	$6.27M	Buy	212,311 +124,696	+142%	+$4.05M	0.01%	1104
2019 Q2	$3.02M	Buy	87,615 +21,514	+33%	+$690K	﹤0.01%	1537
2019 Q1	$2.17M	Buy	66,101 +25,628	+63%	+$757K	﹤0.01%	1710
2018 Q4	$971K	Sell	40,473 -5,962	-13%	-$168K	﹤0.01%	2110
2018 Q3	$1.55M	Buy	46,435 +25,193	+119%	+$797K	﹤0.01%	1960
2018 Q2	$617K	Buy	21,242 +5,312	+33%	+$148K	﹤0.01%	2537
2018 Q1	$410K	Buy	+15,930	New	+$431K	﹤0.01%	2691